Evidence map›Paper›PMID 40125013›Full record

ArticleSkin health and disease2025

Nicolas Lebonvallet, Chloé Catovic, Marc Feuilloley, Raphael Leschiera, Alexia Reux, Matthieu Talagas, Ianis Cousin, Laurent Misery, Emilie Simon, Sylvie Chopin and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Skin health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicolas LebonvalletUniversity of Brest, LIEN, Brest, France.
Chloé CatovicUnité de Recherche 4312 Communication Bactérienne et Stratégies Anti-infectieuses (UR CBSA), Université de Rouen Normandie, Evreux, France.
Marc FeuilloleyUnité de Recherche 4312 Communication Bactérienne et Stratégies Anti-infectieuses (UR CBSA), Université de Rouen Normandie, Evreux, France.
Raphael LeschieraUniversity of Brest, LIEN, Brest, France.
Alexia ReuxUniversity of Brest, LIEN, Brest, France.
Matthieu TalagasUniversity of Brest, LIEN, Brest, France.
Ianis CousinUniversity of Brest, LIEN, Brest, France.
Laurent MiseryUniversity of Brest, LIEN, Brest, France.
Emilie SimonLaboratoires Gilbert, R&D Department, Hérouville St Clair, France.
Sylvie ChopinLaboratoires Gilbert, R&D Department, Hérouville St Clair, France.
Johan GardèresLaboratoires Gilbert, R&D Department, Hérouville St Clair, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Different symptoms are associated with atopic skin, including dryness, pruritus and pain, and affect patients' quality of life. The environment, microbiota, epidermis, immune and nerve cells are all implicated in the pathogenesis of atopic skin. Objectives: To evaluate a new product Methods: A specific mineral composition, Active Oligo Skin complex™, from seawater was developed and included in a balm. The effects of a solution and balm containing the complex were evaluated Results: Conclusions: The Active Oligo Skin complex™ appears to display potent antipruritic and anti-inflammatory activities, both

Identifiers

PMID40125013
PMCPMC11924379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.